Dilated cardiomyopathy Treatment in Private Çevre Hospital

The clinic provides treatment for dilated cardiomyopathy at Private Çevre Hospital in Istanbul, Turkey. Diagnostics may cost around $2,000, while medication management typically runs $500–$1,000. Surgical interventions like device implantation can be around $15,000. The hospital is a multi-specialty center treating over 4,300 patients annually, including many international cases.

Diagnostic Evaluation

A thorough diagnosis is the first step. The cardiac team performs several key tests. These assessments determine the cause and severity of heart muscle weakness.

• Echocardiogram to measure heart size and pumping function.
• Electrocardiogram (ECG) to check heart rhythm.
• Blood tests to rule out other causes like thyroid problems.
• Cardiac MRI for detailed images of the heart muscle.
• Stress testing to see how the heart performs under exertion.

Medical and Device Therapy

Treatment often starts with medication. Doctors prescribe drugs to reduce strain on the heart. These medicines help it pump more efficiently. They also manage symptoms like swelling and shortness of breath. For some patients, a device is needed. This helps control dangerous heart rhythms.

• Medication management with beta-blockers, ACE inhibitors, and diuretics.
• Implantable Cardioverter Defibrillator (ICD) placement to prevent sudden cardiac arrest.
• Cardiac Resynchronization Therapy (CRT) with a special pacemaker to coordinate heartbeats.

Surgical Treatment Options

Surgery is considered for advanced cases. The goal is to improve heart function or replace it. Surgeons at the hospital have extensive experience in these complex procedures.

• Left Ventricular Assist Device (LVAD) implantation. This mechanical pump supports the heart's main pumping chamber.
• Heart transplantation. This is an option for eligible patients when other treatments fail.

The hospital's cardiology team creates a personalized plan for each patient. Contact the clinic to discuss your specific condition and treatment pathway.